Suppression of p53R2 gene expression with specific siRNA sensitizes HepG2 cells to doxorubicin-Reference-Cited by-同舟云学术

Suppression of p53R2 gene expression with specific siRNA sensitizes HepG2 cells to doxorubicin

Published:2018-02 Issue: Volume:642 Page:249-255
ISSN:0378-1119
Container-title:Gene
language:en
Short-container-title:Gene

Author:

Azimi Ako,Majidinia Maryam,Shafiei-Irannejad Vahid,Jahanban-Esfahlan Rana,Ahmadi Yasin,Karimian Ansar,Mir Seyed mostafa,Karami Hadi,Yousefi Bahman^ORCID

Publisher

Elsevier BV

Subject

Genetics,General Medicine

Reference53 articles.

1. Ribonucleotide reductase and cancer: biological mechanisms and targeted therapies;Aye;Oncogene,2015

2. p53R2 is oncogenic in human cervical cancer;Bo;Cell Cycle,2017

3. ATM-mediated serine 72 phosphorylation stabilizes ribonucleotide reductase small subunit p53R2 protein against MDM2 to DNA damage;Chang;Proc. Natl. Acad. Sci.,2008

4. Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells;Chen;Small,2009

5. Novel regulators and molecular mechanisms of p53R2 and its disease relevance;Cho;Biochimie,2016

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming;Molecular Aspects of Medicine;2023-10

2. Effect of siRNA-mediated silencing of p53R2 gene on sensitivity of T-ALL cellsto Daunorubicin;Gene;2023-09

3. The Role of Small Interfering RNAs in Hepatocellular Carcinoma;Journal of Gastrointestinal Cancer;2023-07-11

4. Ribonucleotide reductase subunit switching in hepatoblastoma drug response and relapse;Communications Biology;2023-03-08

5. Ribonucleotide Reductase Subunit Switching in Hepatoblastoma Drug Response and Relapse;2023-01-24